These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 26079252)

  • 21. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
    Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
    Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.
    Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO
    Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
    Thalgott M; Rack B; Eiber M; Souvatzoglou M; Heck MM; Kronester C; Andergassen U; Kehl V; Krause BJ; Gschwend JE; Retz M; Nawroth R
    BMC Cancer; 2015 Jun; 15():458. PubMed ID: 26051431
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Markou A; Tzanikou E; Strati A; Zavridou M; Mastoraki S; Bournakis E; Lianidou E
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397108
    [No Abstract]   [Full Text] [Related]  

  • 25. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
    Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
    BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.
    Pantel K; Alix-Panabières C
    Cancer Discov; 2012 Nov; 2(11):974-5. PubMed ID: 23093252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in prostate cancer - Current clinical utility and future perspectives.
    Kretschmer A; Tilki D
    Crit Rev Oncol Hematol; 2017 Dec; 120():180-193. PubMed ID: 29198331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the Liquid Biopsy in Metastatic Prostate Cancer.
    Moreno JG; Gomella LG
    Urology; 2019 Oct; 132():1-9. PubMed ID: 31207303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumor cells in prostate cancer: beyond enumeration.
    Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients.
    León-Mateos L; Casas H; Abalo A; Vieito M; Abreu M; Anido U; Gómez-Tato A; López R; Abal M; Muinelo-Romay L
    Oncotarget; 2017 Aug; 8(33):54708-54721. PubMed ID: 28903376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
    Aragon-Ching JB; Siegel RS; Frazier H; Andrawis R; Hendricks F; Phillips M; Jarrett T; Guebre-Xabiher H; Patierno S; Simmens SJ
    Clin Genitourin Cancer; 2015 Oct; 13(5):e341-5. PubMed ID: 25956468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer.
    Tulpule V; Morrison GJ; Falcone M; Quinn DI; Goldkorn A
    Curr Oncol Rep; 2022 Oct; 24(10):1287-1298. PubMed ID: 35575959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
    Reichert ZR; Kasputis T; Nallandhighal S; Abusamra SM; Kasputis A; Haruray S; Wang Y; Williams S; Singhal U; Alva A; Cackowski FC; Caram MEV; Palmbos PL; Yentz SE; Smith DC; Alumkal JJ; Morgan TM
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumour cells-monitoring treatment response in prostate cancer.
    Miyamoto DT; Sequist LV; Lee RJ
    Nat Rev Clin Oncol; 2014 Jul; 11(7):401-12. PubMed ID: 24821215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer.
    Osmulski P; Mahalingam D; Gaczynska ME; Liu J; Huang S; Horning AM; Wang CM; Thompson IM; Huang TH; Chen CL
    Prostate; 2014 Sep; 74(13):1297-307. PubMed ID: 25065737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer.
    Chai S; Matsumoto N; Storgard R; Peng CC; Aparicio A; Ormseth B; Rappard K; Cunningham K; Kolatkar A; Nevarez R; Tu KH; Hsu CJ; Malihi P; Corn P; Zurita A; Hicks J; Kuhn P; Ruiz-Velasco C
    Mol Cancer Res; 2021 Dec; 19(12):2036-2045. PubMed ID: 34462330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer.
    Lorente D; Mateo J; de Bono JS
    Am Soc Clin Oncol Educ Book; 2014; ():e197-203. PubMed ID: 24857103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.